Tradestie Institutional Equity Comparison Engine

TRNI vs TLX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TLX Overall Edge

TLX Captures Institutional Edge (2โ€“1 Pillars ยท 7โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Telix Pharmaceuticals Limited American Depositary Shares (TLX) driven by superior Valuation, Growth & Margin while TRNI counters with relative strength in Momentum & Technical. Fundamentally, TRNI trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus TLX at N/M Forward P/E and 6.2% operating margin (+22.3% YoY). In options structure, TRNI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against TLX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner TLX
TRNI N/M vs TLX N/M Fwd P/E
Growth & Margin Winner TLX
Op Margin N/A vs 6.2% ยท YoY N/A vs +22.3%
Momentum & Technical Winner TRNI
1Y -0.9% vs -7.4% ยท 52W Pos 25% vs 31%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
TRNI US Equity
TRNI
Institutional Equity
$25.00
-0.16% 1D
Market Cap N/A
1M Return +0.04%
1Y Return -0.95%
Forward P/E N/M
Unified AI Score
44.3 / 100 HOLD
Tech 48.0 Fund 51.0 Flow 50.0 Mom 50.0
TLX NASDAQ
Telix Pharmaceuticals Limited American Depositary Shares
Pharmaceutical Preparations
$8.37
-3.9% 1D
Market Cap $3.0B
1M Return -12.26%
1Y Return -7.41%
Forward P/E N/M
Unified AI Score
37.6 / 100 SELL
Tech 19.0 Fund 40.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: TRNI -0.95% TLX -7.41% Spread: +15.18 pp (TRNI Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
TRNI TTM Op. Margin: N/A TLX TTM Op. Margin: 6.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TRNI vs TLX. Trailing 12-month operating profitability (TRNI N/A vs TLX 6.2%) and valuation multiples (TRNI N/M vs TLX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: TRNI (2) vs TLX (7)
Institutional Metric TRNI TLX Criterion Row Winner
Market Capitalization Scale N/A $3.0B Larger Scale TLX
Trailing P/E Ratio Valuation N/M 87.1x Lower Multiple TLX
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A +22.3% Higher Growth TLX
Operating Margin (TTM) Profitability N/A 6.2% Higher Margin TLX
Net Profit Margin Profitability N/A 3.8% Higher Margin TLX
Return on Equity (ROE) Capital Efficiency N/A 7.4% Higher ROE TLX
52-Week Range Position Momentum 25% ($25โ€“$25) 31% ($6โ€“$13) Stronger Trend TLX
Beta / 30D Volatility Risk Regime 0.03ฮฒ ยท 3% Vol 0.91ฮฒ ยท 48% Vol Lower Realized Risk TRNI
Unified Institutional Score Composite Signal 44.3 / 100 (HOLD) 37.6 / 100 (SELL) Higher Composite TRNI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full TRNI vs TLX Buy Guide
TRNI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live TRNI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TLX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live TLX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither TRNI nor TLX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.